Hydroxychloroquine might reduce mortality in patients with systemic sclerosis
International Journal of Rheumatic Diseases · 2023
DOI: 10.1111/1756-185x.14670 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Rheumatic Diseases, 2023. Verfasst von Eda Otman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Scleroderma, Localized. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Background
Systemic sclerosis (SSc) is a devastating disease that has a profound impact on life expectancy, reflected by a standardised mortality ratio of 3,5. There is still limited data regarding the predictive factors for mortality in patients with SSc. Determining those factors could guide in disease management and follow up. 1 Objectives: We aimed to identify the predictive factors for death in SSc.
Methods
Patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey.
ORCID-Profile: Eda Otman, Sercan Gucenmez, Dilek Solmaz, Servet Akar, Mustafa Ozmen
Zitieren
APA
Otman, E., Gucenmez, S., Solmaz, D., Akar, S., & Ozmen, M. (2023). Hydroxychloroquine might reduce mortality in patients with systemic sclerosis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14670
Vancouver
Otman E, Gucenmez S, Solmaz D, Akar S, Ozmen M. Hydroxychloroquine might reduce mortality in patients with systemic sclerosis. International Journal of Rheumatic Diseases. 2023. doi:10.1111/1756-185x.14670
BibTeX
@article{Otman2023,
author = {Otman, Eda and Gucenmez, Sercan and Solmaz, Dilek and Akar, Servet and Ozmen, Mustafa},
title = {Hydroxychloroquine might reduce mortality in patients with systemic sclerosis},
journal = {International Journal of Rheumatic Diseases},
year = {2023},
doi = {10.1111/1756-185x.14670}
}
EUVIMED